Upload

Loading icon Loading...

This video is unavailable.

Zyprexa Drug Rep

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to like ridgewayng's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to dislike ridgewayng's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to add ridgewayng's video to your playlist.

Uploaded on Dec 22, 2006

PharmedOut, a new project that educates physicians on how pharmaceutical companies influence prescribing, is previewing a timely video about Zyprexa (olanzapine), an antipsychotic drug approved by the FDA to treat
schizophrenia and bipolar disorder. In this video Shahram Ahari, a former pharmaceutical company representative, tells how he sold the
drug. Nearly a decade after its introduction, a drug once hailed as a breakthrough treatment is being assailed for its negative side effects.
Antipsychotic drugs are not risk-free, but doctors and patients have long complained that Zyprexa causes obesity and diabetes. This week, the New York Times reported that studies on the frequency of weight gain were underreported by the manufacturer. PharmedOut is an independent
physician-run project funded through the Attorney General Consumer and Prescriber Education grant program.

Loading icon Loading...

Loading icon Loading...

Loading icon Loading...

The interactive transcript could not be loaded.

Loading icon Loading...

Loading icon Loading...

Ratings have been disabled for this video.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.

Loading icon Loading...

Loading...
Working...
to add this to Watch Later

Add to